A BIBLIOMETRIC ANALYSIS OF DOMESTIC REVENUE MOBILISATION STRATEGIES IN FRAGILE ECONOMIES (2004- 2025)
Business and Economics in Developing Countries · 2025
DOI: 10.26480//bedc.02.2025.38.44 ↗Kurz gefasst
Fachartikel in der Zeitschrift Business and Economics in Developing Countries, 2025. Verfasst von Fred Konneh Songa Monson.
Themen: Mobilisation
Abstract (Originalsprache)
This research examines the literature regarding the topic of domestic revenue mobilisation (DRM) strategies in fragile economies between the years 2004 and 2025 by applying a bibliometric analysis. It addresses the literature gap in existing literature, which lacks a comprehensive bibliometric analysis focused specifically on DRM in fragile contexts. I analysed 2,221 articles obtained from the Web of Science Core Collection database using the R-bibliometrix package. The results show a considerable growth in the level of academic output, a shift focus from technical tax issues to wider policy concerns, and the development of the global collaborative network, which is dominated by developed countries. The review recommends that policymakers should consider integrating taxation into the development strategies of national frameworks. This review calls for empirical evidence to validate these findings within specific country contexts.
Zitieren
APA
Monson, F. K. S. (2025). A BIBLIOMETRIC ANALYSIS OF DOMESTIC REVENUE MOBILISATION STRATEGIES IN FRAGILE ECONOMIES (2004- 2025). Business and Economics in Developing Countries. https://doi.org/10.26480//bedc.02.2025.38.44
Vancouver
Monson FKS. A BIBLIOMETRIC ANALYSIS OF DOMESTIC REVENUE MOBILISATION STRATEGIES IN FRAGILE ECONOMIES (2004- 2025). Business and Economics in Developing Countries. 2025. doi:10.26480//bedc.02.2025.38.44
BibTeX
@article{Monson2025,
author = {Monson, Fred Konneh Songa},
title = {A BIBLIOMETRIC ANALYSIS OF DOMESTIC REVENUE MOBILISATION STRATEGIES IN FRAGILE ECONOMIES (2004- 2025)},
journal = {Business and Economics in Developing Countries},
year = {2025},
doi = {10.26480//bedc.02.2025.38.44}
}
EUVIMED